tetano
Editor, Senior Moderator
Infect Dis Clin North Am. 2018 Mar;32(1):75-89. doi: 10.1016/j.idc.2017.11.005.
[h=1]Updates on Influenza Vaccination in Children.[/h] Campbell AJP[SUP]1[/SUP], Grohskopf LA[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza vaccination is recommended for all children 6 months of age and older who do not have contraindications. This article provides an overview of information concerning burden of influenza among children in the United States; US-licensed influenza vaccines; vaccine immunogenicity, effectiveness, and safety; and recent updates relevant to use of these vaccines in pediatric populations. Influenza antiviral medications are discussed. Details concerning vaccine-related topics may be found in the current US Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices recommendations for use of influenza vaccines (https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html). Additional information on influenza antivirals is located at https://www.cdc.gov/flu/professionals/antivirals/index.htm.
[h=4]KEYWORDS:[/h] Antiviral; Immunogenicity; Influenza vaccination; Safety; Vaccine effectiveness
PMID: 29406978 DOI: 10.1016/j.idc.2017.11.005
[h=1]Updates on Influenza Vaccination in Children.[/h] Campbell AJP[SUP]1[/SUP], Grohskopf LA[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Influenza vaccination is recommended for all children 6 months of age and older who do not have contraindications. This article provides an overview of information concerning burden of influenza among children in the United States; US-licensed influenza vaccines; vaccine immunogenicity, effectiveness, and safety; and recent updates relevant to use of these vaccines in pediatric populations. Influenza antiviral medications are discussed. Details concerning vaccine-related topics may be found in the current US Centers for Disease Control and Prevention/Advisory Committee on Immunization Practices recommendations for use of influenza vaccines (https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html). Additional information on influenza antivirals is located at https://www.cdc.gov/flu/professionals/antivirals/index.htm.
[h=4]KEYWORDS:[/h] Antiviral; Immunogenicity; Influenza vaccination; Safety; Vaccine effectiveness
PMID: 29406978 DOI: 10.1016/j.idc.2017.11.005